Survival of Infants Born to HIV-positive Mothers, by Feeding Modality, in Rakai, Uganda
Overview
Authors
Affiliations
Background: Data comparing survival of formula-fed to breast-fed infants in programmatic settings are limited. We compared mortality and HIV-free of breast and formula-fed infants born to HIV-positive mothers in a program in rural, Rakai District Uganda.
Methodology/principal Findings: One hundred eighty two infants born to HIV-positive mothers were followed at one, six and twelve months postpartum. Mothers were given infant-feeding counseling and allowed to make informed choices as to whether to formula-feed or breast-feed. Eligible mothers and infants received antiretroviral therapy (ART) if indicated. Mothers and their newborns received prophylaxis for prevention of mother-to-child HIV transmission (pMTCT) if they were not receiving ART. Infant HIV infection was detected by PCR (Roche Amplicor 1.5) during the follow-up visits. Kaplan Meier time-to-event methods were used to compare mortality and HIV-free survival. The adjusted hazard ratio (Adjusted HR) of infant HIV-free survival was estimated by Cox regression. Seventy-five infants (41%) were formula-fed while 107 (59%) were breast-fed. Exclusive breast-feeding was practiced by only 25% of breast-feeding women at one month postpartum. The cumulative 12-month probability of infant mortality was 18% (95% CI = 11%-29%) among the formula-fed compared to 3% (95% CI = 1%-9%) among the breast-fed infants (unadjusted hazard ratio (HR) = 6.1(95% CI = 1.7-21.4, P-value < 0.01). There were no statistically significant differentials in HIV-free survival by feeding choice (86% in the formula-fed compared to 96% in breast-fed group (Adjusted RH = 2.8[95%CI = 0.67-11.7, P-value = 0.16]
Conclusions/significance: Formula-feeding was associated with a higher risk of infant mortality than breastfeeding in this rural population. Our findings suggest that formula-feeding should be discouraged in similar African settings.
ESHRE guideline: medically assisted reproduction in patients with a viral infection/disease.
Mocanu E, Drakeley A, Kupka M, Lara-Molina E, Le Clef N, Ombelet W Hum Reprod Open. 2023; 2021(4):hoab037.
PMID: 36733615 PMC: 9887941. DOI: 10.1093/hropen/hoab037.
Kankaka E, Nalugoda F, Serwadda D, Makumbi F, J Wawer M, H Gray R Afr Health Sci. 2022; 22(Spec Issue):42-50.
PMID: 36321125 PMC: 9590336. DOI: 10.4314/ahs.v22i2.7S.
Bultum E, Roro E, Wolde T, Regasa I PLoS One. 2022; 17(8):e0271167.
PMID: 35939427 PMC: 9359562. DOI: 10.1371/journal.pone.0271167.
Aguti I, Kimbugwe C, Apai P, Munyaga S, Nyeko R Pan Afr Med J. 2021; 37:297.
PMID: 33654517 PMC: 7881925. DOI: 10.11604/pamj.2020.37.297.22928.
Nsubuga-Nyombi T, Karamagi E, Nabitaka L, Namukose S, Calnan J, Nyakwezi S J Int Assoc Provid AIDS Care. 2019; 18:2325958219857724.
PMID: 31258023 PMC: 6748534. DOI: 10.1177/2325958219857724.